Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01309217 · ClinicalTrials.gov registry record · Phase 4
Dissemination of Tobacco Tactics for Hospitalized Smokers
A Phase 4 study of Smoking Cessation, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,528
- Enrollment target
- 6
- Study locations
NCT01309217: Completed Phase 4 study of Smoking Cessation, sponsored by University of Michigan.
NCT01309217 is a Phase 4 study of Smoking Cessation that has completed, run by University of Michigan. The registered enrollment target is 1,528 participants, above the 467-participant average among 188 other Smoking Cessation trials with a reported enrollment target (227% higher). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01309217, a Phase 4 study of Smoking Cessation, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,528 participants
- Enrollment target
- 6
- Study locations
Study Summary
Nurse-administered smoking cessation interventions have been shown to be efficacious, but are seldom implemented due to lack of training and time. This project aims to disseminate and test the nurse-administered Tobacco Tactics intervention in 6 hospitals.
Primary Outcome
The question used to evaluate smoking is: "Have you smoked any cigarette products, even a puff, in the last seven days?" Along with the 6-month survey, patients will be sent a sample for NicAlert urinary test.
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL Tobacco Tactics Intervention
Study Locations (6)
Michigan
- Saint Mary's Healthcare - Grand Rapids
- St. Mary Mercy - Livonia
- Mercy Health Partners - Hackley Campus - Muskegon
- Mercy Health Partners - Mercy Campus - Muskegon
- St. Joseph Mercy - Oakland
- St. Joseph Mercy Hospital - Ypsilanti
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,528 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-03 |
| Phase | Phase 4 |
What the finished NCT01309217 record still lists
NCT01309217 is an interventional study that assigns participants to a tested intervention. Its 1,528 participants enrollment target places it among the larger protocols in the corpus, above the 467-participant average among 188 other Smoking Cessation trials with a reported enrollment target (227% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT01309217 lists 6 locations in 1 state (Michigan).
Frequently Asked Questions
What is clinical trial NCT01309217 about?
NCT01309217 is a clinical study titled "Dissemination of Tobacco Tactics for Hospitalized Smokers". Nurse-administered smoking cessation interventions have been shown to be efficacious, but are seldom implemented due to lack of training and time. This project aims to disseminate and test the nurse-administered Tobacco Tactics intervention in 6 hospitals.
What is the current status of trial NCT01309217?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,528 participants. The study started on 2011-07. Estimated completion is 2014-03.
What conditions does trial NCT01309217 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT01309217?
The interventions under investigation include: Usual Care (OTHER), Tobacco Tactics Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01309217?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01309217 being conducted?
This trial has 6 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01309217's enrollment target sits among peer trials
1,528 12th of 188 higher than 177 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06623097 · 1,528 participants · NA
Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study
- NCT06393374 · 1,530 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- NCT07114510 · 1,530 participants · NA
Optimal Ventilation for Cardiac Arrest
- NCT06257082 · 1,526 participants · NA
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia